article thumbnail

University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients

Imaging Technology

milla1cf Tue, 05/14/2024 - 12:45 May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. Because there is no “typical” hospital or laboratory and many variables exist (e.g.,

Hospital 103
article thumbnail

SNMMI Elects Heather Jacene, MD, as Vice President-Elect at 2024 Annual Meeting

Imaging Technology

SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As She will also raise awareness of nuclear medicine’s value to clinical colleagues and patients and will be laser-focused on breaking down barriers to radiopharmaceutical availability, reimbursement, affordability, and funding.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CMS seeks feedback on issuing separate payment for diagnostic radiopharmaceuticals

Radiology Business

The agency issued its solicitation as part of the 2024 Hospital Outpatient Prospective Payment System proposed rule, released late Thursday.

article thumbnail

IMV: PET scan volumes continue to grow

AuntMinnie

year over year, according to the newly published IMV 2024 PET Market Summary Report. In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. IMV's 2024 PET Market Summary Report explores market trends in U.S. Davin Korstjens.

PET Scan 115
article thumbnail

SNMMI Elects Jean-Luc C. Urbain, MD, PhD, FASNC, as President-Elect at 2024 Annual Meeting

Imaging Technology

milla1cf Mon, 06/10/2024 - 18:25 June 10, 2024 — Jean-Luc C. SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As As SNMMI president-elect, I plan to focus on bringing and integrating radiopharmaceutical theranostics into the clinic to benefit as many patients as possible. “As

article thumbnail

IMV: Nuclear medicine procedure volumes decrease

AuntMinnie

decrease in hospital-based studies and a 2.5% increase in nonhospital-based studies, according to the newly published IMV 2024 NM Market Outlook Report. decrease in total procedures each year, with hospital-based procedures declining by 5.5% and non-hospital procedures increasing by 1.2%. Of these, 5.8 Nonhospitals 2.5%

article thumbnail

Blue Earth Therapeutics Announces Publication of Results from Independent Clinical Experience with 177Lu-rhPSMA-10.1 in Treatment of Metastatic Castrate Resistant Prostate Cancer

Imaging Technology

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 Food and Drug Administration.

Clinic 81